Literature DB >> 2598982

Comparison of haemodynamic effects of nifedipine and molsidomine in patients with coronary artery disease.

M Kyriakidis1, G Vyssoulis, P Sfikakis, C Kyriakidis, C Pitsavos, K Valsamis, V Nomikos, P Toutouzas.   

Abstract

The haemodynamic effects of oral nifedipine 20 mg and molsidomine 4 mg were compared in 24 patients with coronary artery disease. Molsidomine unlike nifedipine caused a significant fall in mean pulmonary artery pressure and left ventricular end-diastolic pressure. Both drugs caused a significant and comparable reduction in systolic and diastolic blood pressure. Although only nifedipine significantly reduced systemic vascular resistance the difference between the drugs was not significant. The heart rate was significantly increased by nifedipine but not by molsidomine. The ejection phase indices were all increased by molsidomine and the increment in the mean normalized systolic ejection rate was significantly greater than that due to nifedipine. The left ventricular end-systolic volume index decreased significantly after molsidomine but not nifedipine. Neither drug significantly affected left ventricular end diastolic volume index, stroke volume index, maximal rate of rise of left ventricular pressure or left ventricular stroke work index.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2598982     DOI: 10.1007/bf00558121

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  35 in total

1.  Analysis of coronary responses to nifedipine alone and in combination with intracoronary nitroglycerin in patients with coronary artery disease.

Authors:  R L Feldman; J A Hill; J B Conti; C R Conti; C J Pepine
Journal:  Am Heart J       Date:  1983-04       Impact factor: 4.749

2.  Paradoxical angina after nifedipine: angiographic documentation.

Authors:  P Schanzenbächer; P Deeg; G Liebau; K Kochsiek
Journal:  Am J Cardiol       Date:  1984-01-15       Impact factor: 2.778

3.  Acute hemodynamic responses to sublingual nifedipine: dependence on left ventricular function.

Authors:  P A Ludbrook; A J Tiefenbrunn; F R Reed; B E Sobel
Journal:  Circulation       Date:  1982-03       Impact factor: 29.690

4.  Acute double blind trial of a new anti-anginal drug: molsidomine.

Authors:  S Guerchicoff; A Vazquez; H Kunik; S Drajer; F Díaz
Journal:  Eur J Clin Pharmacol       Date:  1978-06-19       Impact factor: 2.953

5.  Comparison of hemodynamic responses to nifedipine and nitroprusside in severe chronic congestive heart failure.

Authors:  U Elkayam; L Weber; B Torkan; C R McKay; S H Rahimtoola
Journal:  Am J Cardiol       Date:  1984-05-01       Impact factor: 2.778

6.  Nifedipine therapy for coronary-artery spasm. Experience in 127 patients.

Authors:  E Antman; J Muller; S Goldberg; R MacAlpin; M Rubenfire; B Tabatznik; C S Liang; F Heupler; S Achuff; N Reichek; E Geltman; N Z Kerin; R K Neff; E Braunwald
Journal:  N Engl J Med       Date:  1980-06-05       Impact factor: 91.245

7.  Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonism with hydralazine in chronic refractory congestive heart failure.

Authors:  U Elkayam; L Weber; C R McKay; S H Rahimtoola
Journal:  Am J Cardiol       Date:  1984-07-01       Impact factor: 2.778

8.  Provocation of myocardial ischemic events during initiation of vasodilator therapy for severe chronic heart failure. Clinical and hemodynamic evaluation of 52 consecutive patients with ischemic cardiomyopathy.

Authors:  M Packer; J Meller; N Medina; M Yushak; R Gorlin
Journal:  Am J Cardiol       Date:  1981-11       Impact factor: 2.778

9.  Hemodynamic effects of nifedipine in congestive heart failure.

Authors:  S Matsumoto; T Ito; T Sada; M Takahashi; K M Su; A Ueda; F Okabe; M Sato; I Sekine; Y Ito
Journal:  Am J Cardiol       Date:  1980-09       Impact factor: 2.778

10.  Nifedipine in unstable angina: a double-blind, randomized trial.

Authors:  G Gerstenblith; P Ouyang; S C Achuff; B H Bulkley; L C Becker; E D Mellits; K L Baughman; J L Weiss; J T Flaherty; C H Kallman; M Llewellyn; M L Weisfeldt
Journal:  N Engl J Med       Date:  1982-04-15       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.